Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900
Donate

Dominantly Inherited Alzheimer Network trial completes participant enrollment for two drugs in a phase II/III study of amyloid therapies

Dominantly Inherited Alzheimer Network trial completes participant enrollment for two drugs in a phase II/III study of amyloid therapies
Share or Print this page
Share or Print this page
December 7, 2015
Email: media@alz.org
Media Line: 312.335.4078
Share or Print this page

Dominantly Inherited Alzheimer Network trial completes participant enrollment for two drugs in a phase II/III study of amyloid therapies

Alzheimer's Association

The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia.™ For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.

Keep Up With Alzheimer’s News and Events